Home » Topics » BioWorld Science

BioWorld Science
RSS

Immunic signs license agreement for DHODH inhibitors and nucleoside analogues for viral infections

Sep. 23, 2021

Compound from a new class of antimalarials shows activity in vitro and in vivo

Sep. 23, 2021

MIPS-521 exerts analgesic efficacy through stabilization of GPCR-G protein complex dynamics

Sep. 23, 2021

BeiGene discovers non-receptor tyrosine-protein kinase TYK2 inhibitors

Sep. 23, 2021

ShanghaiTech University describes IKZF1/IKZF3 degradation inducers

Sep. 23, 2021

New IL-17 modulators identified at UCB

Sep. 23, 2021

Shanghai Zheye Biotechnology patents G12C mutant GTPase KRAS inhibitors

Sep. 23, 2021

CLEC4G and CD209 block SARS-CoV-2 entry into host cell

Sep. 23, 2021

AMP-CpG-adjuvanted vaccine confers potent immunity against SARS-CoV-2 infection

Sep. 23, 2021

Oncolytic viruses target GSCs with specific p53 deregulations for personalized glioblastoma therapy

Sep. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...